XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating activities:    
Net income $ 147,138 $ 165,589
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 162,603 158,119
Stock-based compensation expense 56,308 57,893
Deferred taxes (6,548) (50,790)
Loss from divested operations 0 2,075
Loss on extinguishment of debt 44,814 0
Fair value adjustment - equity security 0 (9,120)
Reduction in the carrying amount of operating lease right-of-use assets 62,876 63,692
Amortization and write-off of deferred financing fees 7,487 4,865
Amortization of deferred swap losses from de-designation 10,320 0
Loss on de-designated swaps 476 0
Changes in assets and liabilities:    
Fees receivable, net 369,119 215,132
Deferred commissions 56,094 35,329
Prepaid expenses and other current assets (9,104) (941)
Other assets (3,509) (46,954)
Deferred revenues (210,170) 70,006
Accounts payable and accrued and other liabilities (45,074) (182,294)
Cash provided by operating activities 642,830 482,601
Investing activities:    
Additions to property, equipment and leasehold improvements (60,845) (95,701)
Acquisitions - cash paid (net of cash acquired) 0 (2,295)
Cash used in investing activities (60,845) (97,996)
Financing activities:    
Proceeds from employee stock purchase plan 13,813 13,235
Proceeds from borrowings 2,000,000 5,000
Early redemption premium payment (30,752) 0
Payments of deferred financing fees (23,627) 0
Proceeds from revolving credit facility 327,000 281,000
Payments on revolving credit facility (475,000) (316,000)
Payments on borrowings (2,053,342) (74,612)
Purchases of treasury stock (76,117) (141,436)
Cash used in financing activities (318,025) (232,813)
Net increase in cash and cash equivalents 263,960 151,792
Effects of exchange rates on cash and cash equivalents 8,919 (3,728)
Cash and cash equivalents and restricted cash, beginning of period 280,836 158,663
Cash and cash equivalents, end of period $ 553,715 $ 306,727